Pricing Log in Create free account

DiaMedica Therapeutics, Inc. (DMAC) vs Tectonic Therapeutic, Inc. (TECX)

DiaMedica Therapeutics, Inc. and Tectonic Therapeutic, Inc. are both Biotechnology companies. DiaMedica Therapeutics, Inc. and Tectonic Therapeutic, Inc. are of similar size ($456.1M and $449.2M). Across the 8 metrics below, Tectonic Therapeutic, Inc. leads on 5 and DiaMedica Therapeutics, Inc. on 3.

Valuation

Metric DMAC TECX Biotechnology median
P/E n/m n/m 8.56
P/S n/m n/m 10.17
P/B 11.58 1.89 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA n/m n/m 0.69
EV/Sales n/m n/m 9.64
Earnings yield (8.74%) (20.45%) (29.41%)
Free cash flow yield (7.10%) (17.08%) (23.50%)

Profitability

Metric DMAC TECX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (114.62%) (33.80%) (56.66%)
Return on assets (98.18%) (32.23%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DMAC TECX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (16.67%) 40.70% 30.08%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DMAC TECX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.72 22.29 4.72
Net debt to EBITDA 1.70 3.08 0.96

Dividend

Metric DMAC TECX Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric DMAC TECX Biotechnology median
Market cap 449.20m 456.09m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack